- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03033953
Effects of Native Whey or Milk Supplementation on Adaptations to 12 Weeks of Strength Training in Young and Elderly
Effects of Native Whey and Milk Supplementation on Changes in Muscle Mass and Strength After 12 Weeks of Strength Training in Young and Elderly
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
Increasing or maintaining muscle mass is of great importance for populations ranging from athletes to patients and elderly. Resistance exercise and protein ingestion are two of the most potent stimulators of muscle protein synthesis. Both the physical characteristic of proteins (e.g. different digestion rates of whey and casein) and the amino acid composition, affects the potential of a certain protein to stimulate muscle protein synthesis. Given its superior ability to rapidly increase blood leucine concentrations to high levels, whey is often considered the most potent protein source to stimulate muscle protein synthesis. Native whey protein is produced by filtration of unprocessed milk. Consequently, native whey has different characteristics than milk. Of special interest is the higher amounts of the highly anabolic amino acid leucine in native whey.
The higher levels of leucine can be of great interest for elderly individuals as some studies in elderly has shown an anabolic resistance to the effects of protein feeding and strength training. By increasing levels of leucine one might overcome this anabolic resistance in the elderly.
The aim of this double-blinded, randomized, partial cross-over study is to compare the changes in muscle hypertrophy and strength after a 11 (elderly) or 12 (young) week training intervention with daily supplementation of either 2x20g of native whey or milk proteins in young and elderly individuals. In order to explain potential differences between supplements an acute study investigating acute responses in blood amino acid concentrations and intracellular signalling is planned, in a subgroup of participants, before and after the training intervention.
The investigators hypothesize that native whey will induce greater muscle hypertrophy and strength gains than milk.
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
-
Oslo, Norsko, 0863
- Norwegian School of Sport Sciences
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Healthy in the sense that they can conduct training and testing
- Able to understand Norwegian language written and oral
- Between 20 and 45, or above 70 years of age
Exclusion Criteria:
- Diseases or injuries contraindicating participation
- Use of dietary supplements (e.g. proteins, vitamins and creatine)
- Lactose intolerance
- Allergy to milk
- Allergy towards local anesthetics (xylocain)
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Základní věda
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Čtyřnásobek
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Komparátor placeba: Milk supplementation
11 (elderly) or 12 (young) weeks of strength training and daily supplementation of 2x20g milk protein.
|
|
|
Experimentální: Native whey
11 (elderly) or 12 (young) weeks of strength training and daily supplementation of 2x20g native whey protein.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Lean mass
Časové okno: Before the training intervention
|
Measured by whole body dual x-ray absorptiometry (DXA)
|
Before the training intervention
|
|
Lean mass
Časové okno: After 11-12 weeks of strength training
|
Measured by whole body dual x-ray absorptiometry (DXA)
|
After 11-12 weeks of strength training
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Thigh muscle cross sectional area
Časové okno: Before the training intervention
|
Measured by magnetic resonance imaging (MRI)
|
Before the training intervention
|
|
Thigh muscle cross sectional area
Časové okno: After 11-12 weeks of strength training
|
Measured by magnetic resonance imaging (MRI)
|
After 11-12 weeks of strength training
|
|
Pectoralis muscle cross sectional area
Časové okno: Before the training intervention
|
Measured by magnetic resonance imaging (MRI)
|
Before the training intervention
|
|
Pectoralis muscle cross sectional area
Časové okno: After 11-12 weeks of strength training
|
Measured by magnetic resonance imaging (MRI)
|
After 11-12 weeks of strength training
|
|
Arm cross sectional area
Časové okno: Before the training intervention
|
Measured by magnetic resonance imaging (MRI)
|
Before the training intervention
|
|
Arm cross sectional area
Časové okno: After 11-12 weeks of strength training
|
Measured by magnetic resonance imaging (MRI)
|
After 11-12 weeks of strength training
|
|
Thickness of the lateral vasti
Časové okno: Before the training intervention
|
Measured by ultrasound
|
Before the training intervention
|
|
Thickness of the lateral vasti
Časové okno: After 11-12 weeks of strength training
|
Measured by ultrasound
|
After 11-12 weeks of strength training
|
|
1 repetition maximum in leg press
Časové okno: Before the training intervention
|
Before the training intervention
|
|
|
1 repetition maximum in leg press
Časové okno: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
|
1 repetition maximum in bench press
Časové okno: Before the training intervention
|
Before the training intervention
|
|
|
1 repetition maximum in bench press
Časové okno: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
|
Ratio of phosphorylated to total ribosomal protein S6 kinase beta-1(P70S6K) change from baseline
Časové okno: 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
|
Ratio of phosphorylated to total ribosomal protein S6 kinase beta-1(P70S6K) change from baseline
Časové okno: 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Phosphorylation of phosphorylated to total eukaryotic elongation factor 2 (eEF-2) change from baseline
Časové okno: 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
|
Phosphorylation of phosphorylated to total eukaryotic elongation factor 2 (eEF-2) change from baseline
Časové okno: 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Phosphorylation of phosphorylated to total eukaryotic translation initiation factor 4E-binding protein 1 (4EBP-1) change from baseline
Časové okno: 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
|
Phosphorylation of phosphorylated to total eukaryotic translation initiation factor 4E-binding protein 1 (4EBP-1) change from baseline
Časové okno: 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Plasma amino acid concentration
Časové okno: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
|
Plasma amino acid concentration
Časové okno: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
|
Muscle force generating capacity change from baseline
Časové okno: 15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, before the training intervention
|
Measured as unilateral isometric knee extension force (Nm) with 90° in the hip and knee joints.
|
15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, before the training intervention
|
|
Muscle force generating capacity change from baseline
Časové okno: 15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Measured as unilateral isometric knee extension force (Nm) with 90° in the hip and knee joints.
|
15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Serum glucose
Časové okno: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
|
Serum glucose
Časové okno: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
|
Serum insulin
Časové okno: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
|
Serum insulin
Časové okno: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
|
Serum urea
Časové okno: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
|
Serum urea
Časové okno: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
|
Serum creatine kinase
Časové okno: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
|
Serum creatine kinase
Časové okno: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
|
Tumor necrosis factor alfa messenger ribonucleic acid (mRNA)
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Tumor necrosis factor alfa mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Tumor necrosis factor alfa mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Tumor necrosis factor alfa mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 6 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 6 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 6 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 6 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 8 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 8 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 8 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 8 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 1b mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 1b mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 1b mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 1b mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 1 Receptor Antagonist mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 1 Receptor Antagonist mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 1 Receptor Antagonist mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 1 Receptor Antagonist mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 2 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 2 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 2 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 2 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 4 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 4 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 4 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 4 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 10 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 10 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 10 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 10 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-X-C Motif Chemokine Ligand mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
C-X-C Motif Chemokine Ligand mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
C-X-C Motif Chemokine Ligand mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-X-C Motif Chemokine Ligand mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Cholesterol 25-Hydroxylase mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Cholesterol 25-Hydroxylase mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Cholesterol 25-Hydroxylase mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Cholesterol 25-Hydroxylase mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 8 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 8 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 8 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 8 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 17D mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Interleukin 17D mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Interleukin 17D mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Interleukin 17D mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 3 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 3 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 3 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 3 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 5 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 5 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
C-C Motif Chemokine Ligand 5 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
C-C Motif Chemokine Ligand 5 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Uncoupling Protein 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Uncoupling Protein 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Uncoupling Protein 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Uncoupling Protein 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Matrix Metallopeptidase 9 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Matrix Metallopeptidase 9 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Matrix Metallopeptidase 9 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Matrix Metallopeptidase 9 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Toll Like Receptor 2 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Toll Like Receptor 2 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Toll Like Receptor 2 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Toll Like Receptor 2 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 3 Member 2 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 3 Member 2 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 3 Member 2 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 3 Member 2 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 7 Member 5 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 7 Member 5 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 7 Member 5 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 7 Member 5 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 36 Member 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 36 Member 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 36 Member 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 36 Member 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 38 Member 2 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 38 Member 2 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Solute Carrier Family 38 Member 2 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Solute Carrier Family 38 Member 2 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Atrogin-1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Atrogin-1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Atrogin-1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Atrogin-1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Forkhead Box Protein O1A mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Forkhead Box Protein O1A mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Forkhead Box Protein O1A mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Forkhead Box Protein O1A mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Forkhead Box O3 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Forkhead Box O3 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Forkhead Box O3 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Forkhead Box O3 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myosin Heavy Chain 7 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Myosin Heavy Chain 7 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Myosin Heavy Chain 7 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myosin Heavy Chain 7 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myosin Heavy Chain 2 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Myosin Heavy Chain 2 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Myosin Heavy Chain 2 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myosin Heavy Chain 2 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Myosin Heavy Chain 1mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Časové okno: 30 min after exercise and protein intake, after 11-12 weeks of strength training
|
30 min after exercise and protein intake, after 11-12 weeks of strength training
|
|
|
Fasting cholesterol (only in elderly)
Časové okno: Before training intervention
|
Before training intervention
|
|
|
Fasting cholesterol (only in elderly)
Časové okno: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
|
Fasting triglycerides (only in elderly)
Časové okno: Before training intervention
|
Before training intervention
|
|
|
Fasting triglycerides (only in elderly)
Časové okno: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
|
Fasting LDL (only in elderly)
Časové okno: Before training intervention
|
Before training intervention
|
|
|
Fasting LDL (only in elderly)
Časové okno: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
|
Fasting HDL (only in elderly)
Časové okno: Before training intervention
|
Before training intervention
|
|
|
Fasting HDL (only in elderly)
Časové okno: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
Spolupracovníci a vyšetřovatelé
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další identifikační čísla studie
- Tine 12wk
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Zdravý
-
University of ZurichDokončenoOutcome Assessment, Health CareŠvýcarsko
-
University of BernUniversity Hospital Inselspital, BerneDokončenoNeuroscience of Dreaming, HealthŠvýcarsko
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development... a další spolupracovníciDokončenoPreventivní zdravotní služby (PREV HEALTH SERV)Spojené státy
-
Queens College, The City University of New YorkNáborZveřejnění článků předložených American Journal of Public HealthSpojené státy
-
Seattle Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development... a další spolupracovníciZatím nenabírámePreventivní zdravotní služby (PREV HEALTH SERV)Spojené státy
-
University of WashingtonNational Institute of Environmental Health Sciences (NIEHS)Aktivní, ne náborTeplo | Havarijní připravenost | Extrémní teplo | Health Health | Extrémní tepelné vlny | Řízení katastrof | Plánování katastrof | KatastrofySpojené státy
-
Kliniek ViaSanaSt. Anna Ziekenhuis, Geldrop, NetherlandsDokončenoBolest | Užívání opioidů | Totální náhrada kolena | Aplikace E-healthHolandsko
-
Universidad de ZaragozaNáborProfesionální integrace nově odstupňovaných pracovních terapeutů | Peer Mentorship in Health Professions | Přechod včasného kariéry a profesní identitaŠpanělsko
-
Gümüşhane UniversıtyKaradeniz Technical UniversityDokončenoRegistrováno u Kelkit District State Hospital Home Health Unit | Být pacientem domácí péčeKrocan
-
FIDMAG Germanes HospitalàriesUniversity of BarcelonaDokončenoPorucha duševního zdraví | Duševní zdraví wellness 1 | Role sestry | Care Acceptor, Health | Vztah, sestra pacientaŠpanělsko
Klinické studie na Silový trénink
-
Trinitas Comprehensive Cancer CenterAptium Oncology Research NetworkNeznámýRakovina prsuSpojené státy
-
Ancilia BiosciencesNábor
-
Florida State UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH)Dokončeno
-
Appalachian State UniversityHerbalife International of America, Inc.Dokončeno
-
University Hospital, Basel, SwitzerlandDokončenoVývoj dítěte | Studie proveditelnosti | Primární zdravotní péče | Svalová síla | Odporový trénink | Školy | Preventivní zdravotní služby | Školy / organizace a správaŠvýcarsko
-
University of CincinnatiEunice Kennedy Shriver National Institute of Child Health and Human Development...DokončenoCévní mozková příhoda, ischemická | Dysfagie, orální fázeSpojené státy
-
University of FloridaDepartment of Health and Human Services; Georgia State UniversityDokončenoDeprese | Kvalita života | Duševní zdraví | Starší dospělí | Osamělost | Riziko sebevraždy | Společenská izolace | Chování při hledání pomoci | Sociální fungování | Zmařená sounáležitost | Vnímaná zátěž | Sebevražedné myšlenkySpojené státy
-
Northwestern UniversityNáborObstrukční spánková apnoe (OSA)Spojené státy
-
Inés Llamas-RamosNáborRoztroušená skleróza | Svalová slabost | Tréninková skupina, CitlivostŠpanělsko